Skip to main content

CXC-chemokine regulation and neutrophil trafficking in hepatic ischemia-reperfusion injury in P-selectin/ICAM-1 deficient mice



Neutrophil adhesion and migration are critical in hepatic ischemia and reperfusion injury (I/R). P-selectin and the intercellular adhesion molecule (ICAM)-1 can mediate neutrophil-endothelial cell interactions, neutrophil migration, and the interactions of neutrophils with hepatocytes in the liver. Despite very strong preclinical data, recent clinical trials failed to show a protective effect of anti-adhesion therapy in reperfusion injury, indicating that the length of injury might be a critical factor in neutrophil infiltration. Therefore, the aim of this study was to assess the role of P-selectin and ICAM-1 in neutrophil infiltration and liver injury during early and late phases of liver I/R.


Adult male wild-type and P-selectin/ICAM-1-deficient (P/I null) mice underwent 90 minutes of partial liver ischemia followed by various periods of reperfusion (6, 15 h, and a survival study). Liver injury was assessed by plasma level of alanine aminotransferase (ALT) and histopathology. The plasma cytokines, TNF-α, IL-6, MIP-2 and KC, were measured by ELISA.


Reperfusion caused significant hepatocellular injury in both wild-type and P/I null mice as was determined by plasma ALT levels and liver histopathology. The injury was associated with a marked neutrophil infiltration into the ischemic livers of both wild-type and P/I null mice. Although the levels of ALT and neutrophil infiltration were slightly lower in the P/I null mice compared with the wild-type mice the differences were not statistically significant. The plasma cytokine data of TNF-α and IL-6 followed a similar pattern to ALT data, and no significant difference was found between the wild-type and P/I null groups. In contrast, a significant difference in KC and MIP-2 chemokine levels was observed between the wild-type and P/I null mice. Additionally, the survival study showed a trend towards increased survival in the P/I null group.


While ICAM-1 and P-selectin does not appear to be critical for neutrophil infiltration and I/R injury in the liver, they may regulate CXC-chemokine production. Blockage of these adhesion molecules may improve survival and remote organ injury that often accompanies liver I/R injury, through chemokine regulation.


Hepatic I/R injury can result from surgical resection or transplantation of the liver, from portal triad cross-clamping for control of hemorrhage in hepatic trauma, or after hemodynamic shock. In these situations, after a period of ischemia, the liver can be significantly injured upon its reperfusion [1]. If the injury is severe enough, this can lead to liver failure, systemic inflammatory response syndrome, acute respiratory distress syndrome, and multiple organ dysfunction syndrome, which are all associated with high rates of morbidity and mortality.

Hepatic I/R injury occurs in a biphasic pattern: The acute injury phase is characterized by hepatic injury occurring within 1–6 h after reperfusion, associated with Kupffer cell activation, and generation of reactive oxygen species (ROS) and the pro-inflammatory cytokines [2, 3]. This is followed by the subsequent subacute-phase response that is characterized by a massive neutrophil infiltration, peaking 9–24 h following reperfusion. Neutrophil adhesion and migration is dependent on selectins, β 2 integrins (i.e., CD18: Mac-1, LFA-1) and members of the immunoglobulin gene superfamily adhesion molecules such as ICAM-1 [46]. The adherence of neutrophils to hepatocytes can be mediated by Mac-1/ICAM-1, Mac-1/unknown ligand(s) and lymphocyte function-associated antigen (LFA-1)/ICAM-1 [46].

Studies of endotoxin-induced liver injury have suggested an adherence-dependent neutrophil induced hepatocyte injury [7], while others indicated an adherence-independent cytotoxicity of the hepatocytes [8]. P-selectin and ICAM-1 involvement in neutrophil infiltration and I/R injury has been documented in several studies [913]. Likewise, other studies have reported a lack of significant role of these adhesion molecules in the liver I/R injury [7, 1315]. Additionally, recent clinical trials of anti-adhesion therapy in an attempt to reduce injury associated with traumatic shock and reperfusion injury failed to show a significant benefit, despite very strong preclinical data [16]. In an effort to understand the disparity between the preclinical and clinical trial studies, it was noted that the lengths of injury in the clinical setting were longer than those of the preclinical studies. It appears that the underlying mechanism of neutrophil infiltration with a short period of insult is different from those of injury associated with a longer period of insult. Therefore, we examined the role P-Selectin and ICAM-1 in liver reperfusion injury, at various lengths of reperfusion time. In the current study, we sought to test whether or not hepatic I/R injury would be attenuated in P/I null mice after longer periods of reperfusion, at time points most consistent with the neutrophil-mediated phase of liver injury.


All chemicals were purchased from Sigma Chemical (St. Louis, MO), unless otherwise noted.


Adult male mice (i.e., 8–10 wk) were used in this study. All animals received humane care in compliance with the Guide for the Care and Use of Laboratory Animals (National Institutes of Health Publication No. 85-23, revised 1985). Experimental protocols were approved by the Michigan State University Animal Use and Care Committee.

Gene-targeted double mutant mice deficient in P-selectin and ICAM-1 (P/I double mutant), C57BL/6-Icam1tm1BaySelptm1Bay, were used in this study. The breeding pairs of double-knockout mice were purchased from Jackson Laboratory (Bar Harbor, ME) and bred under the guidance of University Laboratory Animal Resources at Michigan State University. The wild-type mice were male C57BL/6. Before and after surgery, all the animals had unlimited access to food and water.

A murine model of lobar hepatic ischemia, as previously described by our laboratory, was used [13]. The experimental procedures were performed under aseptic conditions. Adult male mice (8–10 wk) weighing between 23–30 g were anesthetized with inhaled methoxyflurane (Baxter Caribe, Inc., Guayama, PR) followed by an intraperitoneal injection (35 mg/kg body wild-type) of sodium pentobarbital (Abbott Laboratories, North Chicago, IL). A midline laparotomy was performed. The ligamentous attachments of the left lateral and median lobes were carefully divided. The left lateral and median lobes were freed. The portal circulation to both of these lobes was carefully dissected and the portal vein and hepatic artery supplying the median and left lateral lobes were then interrupted with an atraumatic vascular clamp (Accurate Surgical and Scientific Instruments Corporation, Westbury, NY). The left lateral lobe was also rotated 180 degrees counter-clockwise on its vascular pedicle to eliminate any potential perfusion that might occur with an imperfect clamp occlusion. The caudate and right lateral lobes, as well as the papillary and quadrate processes, retained an intact portal and arterial inflow and venous outflow to prevent intestinal venous congestion. This procedure resulted in the induction of ischemia to approximately 65–70 percent of the liver. The mortality due to the surgical procedure was minimal (< 1–2%). After 90 minutes of partial hepatic ischemia the clamp was removed, the left lobe was rotated back 180 degrees clockwise, and reperfusion was initiated. The midline laparotomy was closed in a single layer fashion using 5-0 nylon suture. Sterile lactated Ringer's solution (0.8 ml) was administered subcutaneously to compensate for operative blood and fluid losses. Animals were divided into two groups; the test group underwent I/R and the sham group underwent the same anesthesia and midline laparotomy dissection of the portal vessels and liver, but without vascular occlusion. Mice were euthanized after 6 and 15 h of reperfusion and the blood and liver tissue were collected and processed, as described below. Additionally, a survival study was carried on in which the length of survival from the start of reperfusion was recorded up to three weeks at the time the mice were euthanized.

Peripheral blood and tissue procurement

Blood samples were collected from the right ventricle via a left anterior thoracotomy in a sterile heparinized syringe containing 50 μl of heparin (100 USP Units/ml). The blood samples were centrifuged and plasma were collected and stored at -30°C until further use. Portions of the ischemic and non-ischemic liver lobes were fixed in buffered 10% formalin, embedded in paraffin, and used for hematoxylin and eosin (H&E) staining. Other portions of ischemic and non-ischemic liver lobes were snap frozen in liquid nitrogen and stored at -70°C, until use for immunohistochemistry staining, and MPO analysis.

Demonstration of hepatocellular injury by determination of plasma alanine aminotransferase levels

The plasma ALT levels were determined spectraphotometrically, as previously described [13]. The ALT values are expressed in international units per liter (IU/L).

Histopathological studies

H&E staining was performed on tissue sections prepared at 5-μm intervals. A pathologist, blinded to the experimental procedure of the mice, examined the histopathology of the hepatic tissue sections.

Immunohistochemistry for ICAM-1 expression and neutrophil sequestration

ICAM-1 expression of the hepatic tissue was detected by an immunohistochemistry technique as previously published by our laboratory [13]. Briefly, cryosections (5-um thick) from ischemic and nonischemic hepatic lobes fixed in acetone were stained using an anti-mouse ICAM-1 antibody (3E2, IgG, Pharmingen, San Diego, CA) and a biotin-conjugated goat anti-hamster IgG secondary antibody (Pharmingen). ICAM-1 molecules were visualized using a Vectastain avidin-biotin complex reagent and 3,3'-diaminobenzidine chromogen kits (Vector Lab, Inc., Burlingame, CA). The tissue sections were examined using a Nikon light microscope interfaced with a Spot 24-Bit Digital Color Camera. Similarly, immunohistochemical staining for neutrophils was performed using a primary antibody (IgG2a) specific to the mouse neutrophil (Cedarlane International Distributor, Ontario, Canada).

Plasma cytokine concentrations

Plasma TNF-α, IL-6, KC, and MIP-2 levels were determined in a 96-well Nunc-Immuno microplate (VWR Scientific, Chicago, IL), using a sandwich e nzyme-l inked i mmunos orbent a ssay (ELISA) technique, as previously described [17]. The capture antibody was a polyclonal anti-mouse TNF-α, IL-6, KC, or MIP-2 specific goat IgG (R&D Systems, Minneapolis, MN) and the detection antibody was a biotinylated polyclonal anti-mouse TNF-α, IL-6, KC or MIP-2 specific goat IgG, (R&D Systems). All plasma samples were tested in duplicate. The minimal detectable protein concentration was 20 pg/ml.

Demonstration of neutrophil recruitment by myeloperoxidase (MPO) assay

Liver MPO content was measured according to the previously published method by our laboratory [17]. Briefly, the frozen liver tissues were homogenized using a Tissue Tearor, centrifuged and the pellets were resuspended in the buffer. The MPO activity was determined using a tetramethylbenzidine substrate kit (ImmunoPure, Pierce, Rockford, IL) and read at 450 nm using a human MPO as a standard. One unit of MPO activity was defined as the quantity of enzyme degrading 1 μmol peroxide/min at 25°C.

Statistical analysis

All data are expressed as means ± SEM. Comparison between two groups was performed using an unpaired Student t-test. Comparisons between multiple groups and various time points were performed using a Kruskal-Wallis One-Way Analysis of Variance (ANOVA) followed by a Bonferroni test. Survival data was assessed using the Kaplan-Meier log rank test. Analysis was performed using the Number Cruncher Statistical System (Number Cruncher Statistical Systems, Kaysville, UT). P ≤ 0.05 was considered significant.


Verification of ICAM-1 deficiency in P/I null mice

The absence of ICAM-1, and P-selectin expression in the P/I null mice was confirmed in randomly selected litter mice by specific immunohistochemical staining and reverse transcriptase polymerase chain reaction (RT-PCR), as previously published by our laboratory [13]. The ICAM-1 expression was determined in all the animals used in this study. ICAM-1 was constitutively expressed in the wild-type control mice as indicated by brown staining along endothelial lining of the sinusoids, and hepatic vasculatures (Figure 1A). The ICAM-1 expression was markedly increased in wild-type mice following hepatic I/R (Figure 1C). In contrast, in P/I null liver tissue, ICAM-expression was absent (Figures 1B and 1D). The RT-PCR data are not shown.

Figure 1
figure 1

Immunohistochemical Staining of Liver for ICAM-1 Expression. Positive ICAM-1 staining (brown color) is demonstrated in wild-type mice along the vasculature and sinusoids, but is notably absent in the P/I null mice. (A) Control, wild-type mouse, (B) Control, P/I null mouse, (C) Wild-type mouse after 90 minutes of ischemia and 6 h of reperfusion, (D) P/I null mouse after 90 minutes of ischemia and 6 h of reperfusion.

Demonstration of hepatocellular injury by changes in plasma ALT levels

Hepatic I/R caused significant hepatocellular damage as demonstrated by plasma ALT levels. The plasma ALT levels of both wild-type and P/I null mice after 90 minutes of ischemia followed by 6 and 15 h of reperfusion were significantly elevated when compared to their respective sham-operated mice (Figure 2). ALT levels were negligible in both groups by the survival time-point. Although there was no statistically significant difference in ALT levels between the wild-type and P/I null mice at either time point of reperfusion (i.e. 6 and 15 h), P/I null mice showed decreased ALT levels compared to the wild-type mice.

Figure 2
figure 2

Time-course of plasma ALT levels following hepatic I/R. Mice were subjected to 90 minutes of ischemia followed by reperfusion with various lengths of time. "Control" indicates mice that underwent no surgical procedure. "Sham" indicates mice that underwent surgical procedure with no vascular occlusion followed by reperfusion, while "I/R" denote mice that underwent I/R surgical procedure. Values are expressed as mean ± SEM. (*) Sham-operated mice were statistically different from the I/R groups (i.e., p ≤ 0.05). Sham and P/I group (n = 3–16 mice per each data time point).

Demonstration of hepatocellular injury by histopathology

The histopathologic injury of the liver tissue was evaluated based on sinusoidal congestion, cytoplasmic vacuolization, hepatocellular necrosis, and neutrophil infiltration. The liver sections from the sham-operated mice displayed minimal/no necrosis, similar to that of the non-operated control mice (Figure 3A and 3B). Additionally, there was no apparent evidence of hepatic injury due to ischemia alone (i.e., at zero hour of reperfusion; image not shown). However, reperfusion of the ischemic liver induced an extensive hepatocellular necrosis, sinusoidal congestion, and neutrophil infiltration after 6 and 15 h of reperfusion in both wild-type and P/I null mice (Figures 3C, 3D, 3E, and 3F). There was sparing of the periportal areas with progressively increased injury approaching the central vein. In general, it appeared that the wild-type I/R mice exhibited larger areas of coagulative necrosis when compared to the P/I null mice. The injury was associated with a marked number of neutrophils infiltrated into the midzonal region of ischemic liver after 6 and 15 h of reperfusion in both wild-type and P/I null mice, which was confirmed with in situ immunohistochemical staining of the neutrophils (Figure 3, last row). There were a minimal number of neutrophils present in the livers of sham-operated mice and in the non-ischemic lobes of mice subjected to I/R, indicating that ischemia was a pre-requisite for reperfusion injury to occur. Further, neutrophil infiltration was quantitated by measuring the liver MPO content (Figure 4). The liver MPO levels of both wild-type and P/I null mice after 90 minutes of ischemia followed by 6 and 15 h of reperfusion were significantly elevated compared to the sham-operated mice at the corresponding time points. Further, there was no statistically significant difference in MPO levels between the wild-type and P/I null mice, at either time point.

Figure 3
figure 3

Hepatic histopathology following I/R. Wild-type and P/I null mice subjected to the sham operation or 90 minutes of liver ischemia followed by various reperfusion times. The ischemic liver sections were prepared and stained with H&E. Figures A and B represent the sham mice; there is essentially normal hepatic histology; and C, D, E, and F represent mice subjected to I/R. A pattern of reperfusion damage is evident by loss of hepatocytes in the pericentral and midzonal regions, with relative sparing of the periportal areas. Note the presence of neutrophils in the midzonal region around the central vein. Figures G and H show immunohistochemical staining of neutrophils using a specific anti-neutrophil antibody, i.e., subjected to 90 minutes of ischemia followed 6 h of reperfusion. Neutrophils are indicated by dark brown color stain. (A) Wild-type mouse, 6 hour sham; (B) P/I null mouse, 6 hour sham; (C and E) Wild-type mice subjected to 90 minutes of ischemia followed by 6 and 15 h of reperfusion respectively; (D and F) P/I null mouse subjected to 90 minutes of ischemia followed by 6 and 15 h of reperfusion, respectively.

Figure 4
figure 4

Hepatic Myeloperoxidase Levels following I/R in Wild-type and P/I null mice. Mice were subjected to the sham operation or to 90 minutes of liver ischemia with various reperfusion times (i.e., 6, and 15 hrs). The ischemic liver was collected and its MPO content was determined for the reperfusion time points indicated. Values are expressed as the mean ± SEM. (*) Sham-operated mice were statistically different from the I/R groups (i.e., p ≤ 0.05). Comparison between Wild-type and P/I null at each time points indicated no significant differences.

Plasma TNF-α, IL-6, MIP-2, and KC levels

In order to determine whether plasma cytokine/chemokine levels correlated with tissue injury, the plasma cytokine/chemokine levels were measured using an ELISA. As figure 5 displays, the plasma levels of all cytokines (i.e., TNF-α, IL-6, MIP-2, and KC) were significantly increased in response to I/R, in both the wild-type and P/I null groups, and reached their maximum at 6 h of reperfusion, which then declined to baseline by 15 h of reperfusion. The data related to the wild-type is consistent with our previous studies, where a similar pattern was observed in wild-type mice subjected to hepatic I/R [20].

Figure 5
figure 5

Time-course of plasma TNF-α, IL-6, KC, and MIP-2 levels following various reperfusion times, after the onset of 90 minutes of ischemia. "Control" indicates mice that underwent no surgical procedure. "Sham" indicates mice that underwent surgical procedure with no vascular occlusion followed by reperfusion, while "I/R" indicates mice that underwent surgical procedure with vascular occlusion for 90 minutes followed by reperfusion for various lengths of time. Values are expressed as mean ± SEM. *P < 0.05 wild-type group vs. P/I group (n = 3–16 mice per each time point/group). A: TNF-α data; B: IL-6 data; C: KC data; D: MIP-2 data.

As Figure 5A. shows, hepatic IR caused significant production of TNF-α, by 6 h of reperfusion in both wild-type and P/I mice, which declined by 15 h of reperfusion. However, the data indicates no significant difference in I/R-induced TNF-α production between the wild-type and P/I mice. This data is consistent with plasma ALT data, which showed a maximal increase in ALT levels at I/R 6 h, followed by a decrease in levels by I/R 15 h of reperfusion. A similar pattern was observed in plasma IL-6 levels (Figure 5B). In contrast, chemokine production showed a different pattern, in that the P/I null mice had significantly lower levels of plasma KC and MIP-2 at I/R 6 h than the wild-type mice (Figure 5C. and 5D).

Survival study

Ten wild-type and ten P/I null mice were subjected to 90 minutes of partial hepatic ischemia and were observed post-operatively and their approximate times of death were recorded. At the end of three weeks, all surviving mice were euthanized. All the P/I null mice survived the full three weeks while only 7 out of 10 of the wild-type mice survived that length of time. The Kaplan-Meier log rank test showed no statistically significant difference between the two groups (p = 0.067), although a trend towards improved survival in the P/I null group was apparent (Figure 6).

Figure 6
figure 6

Kaplan-Meier Survival Curve. Mice were subjected to 90 minutes of liver ischemia followed by a 3-week period of reperfusion. The plot shows two curves. The solid line represents the survival curve for the P/I null mice (10/10 mice survived) and the broken line represents the survival curve for the wild-type mice (7/10 mice survived). Wild-type survival was not significantly different from P/I null survival (p = 0.067) although a trend is apparent.


Neutrophil infiltration plays an important role in reperfusion tissue injury, which is mediated by adhesion molecules such as selectins, β2-integrins, and ICAM-1. It has been suggested that inhibition of the adhesion molecules would prevent neutrophil infiltration, thus providing protection against organ injury caused by I/R. Currently though, there is a disparity between preclinical and clinical trial data, and it has been suggested that this disparity may be the result of the length of insult used in previous studies. Thus, the current study examined the role of P-selectin and ICAM-1, adhesion molecules involved in cytokine production, neutrophil infiltration, and hepatocellular injury, following hepatic I/R injury after short and longer periods of insult. Transgenic P/I null and wild-type mice were subjected to 90 minutes of warm liver ischemia followed by various periods of reperfusion. Hepatic I/R caused significant hepatocellular injury at 6 and 15 h of reperfusion in both wild-type and P/I null mice, which was associated with a marked increase in neutrophil infiltration to the ischemic liver. The difference between the two mouse groups was moderate and statistically insignificant. In contrast, there was a significant difference in CXC-chemokine production in that the P/I null mice had significantly lower levels CXC-chemokines than their wild-type mice counterparts. Additionally, P/I null mice showed a favorable trend to survival. These findings suggested that while P-selectin and ICAM-1 do not play a critical role for neutrophil infiltration and liver injury, it may regulate chemokine production and confer a survival advantage.

The data of the present study is consistent with previously reported studies that demonstrated no attenuation of neutrophil infiltration in hepatic sinusoids despite blocking a number of different adhesion molecules [14, 1820]. Studies have also shown that neutrophil infiltration was largely independent of the adhesion molecules, despite the presence of adhesion molecules on endothelial cells lining the hepatic sinusoids and vasculature [21, 22]. In contrast, other studies have shown that neutrophil infiltration was dependent on the adhesion molecules and that hepatocellular injury was reduced by anti-adhesion antibody treatment [10, 21]. These studies collectively indicate that the role of adhesion molecules is tissue and stimulus specific. As discussed below, there are a number of possible explanations as to why P-selectin and ICAM-1 deficiency did not appear to be critical for neutrophil infiltration and hepatocellular injury following liver I/R.

Although P-selectin is considered a critical adhesion molecule in initial tethering and rolling of neutrophils on endothelial cells, several studies suggest that P-selectin is unlikely to play an important role in hepatic injury through neutrophil sequestration or transendothelial migration. First, P-selectin is not expressed on the sinusoidal endothelium [22, 23], where the predominant neutrophil extravasation takes place in the liver [7]. Second, within the liver venules, leukocytes can use other adhesion molecules such as α-4 integrin, independent of the selectins, and finally, within the liver sinusoids, no known selectin molecules or α-4 integrin molecules appear to play a dominant role in leukocyte recruitment [24]. Nevertheless, it should be noted that P-selectin might participate in I/R injury through its role in platelet aggregation and binding to the neutrophils [25]. Other factors such as swelling of the endothelial lining cells, vasoconstriction of the sinusoids, and, stiffening and decreased deformability of the neutrophils, may also contribute to the mechanical trapping of neutrophils in hepatic sinusoids. [26, 27].

The study presented in this article suggests an ICAM-1 independent mediated neutrophil infiltration into the ischemic liver, though it has to be noted that P/I null mice are not true ICAM-1 knockouts. The P/I null mice may have had low levels of alternatively spliced forms of ICAM-1 that could have been up-regulated on the vascular endothelium, and thereby promoted neutrophil migration [28, 29]. However, this possibility is remote, since the 3E2 mAb that was used in the present study corresponds to the common form of ICAM-1. Further, the lack of ICAM-1, per se, is not a critical factor that results in dysfunctional β2-integrin-mediated migration. Finally, other adhesion molecule(s), ligand(s), and/or yet unknown counter-receptor(s) might also mediate neutrophil infiltration. For example, ICAM-2, a ligand for β2-integrins, and α4-integrins (α4β1/VLA-4 and α4β1/VCAM-1), could be potential candidates [3034]. In addition, neutrophils also express CD11d/CD18 and α9-integrin, which both bind to VCAM-1, and could possibly play an important role in neutrophil extravasation, at sites of inflammation [35]. The importance of α4- and α 9-integrin/VCAM-1 pathways in neutrophil infiltration in I/R-induced hepatic injury remains unclear. Further, other proteins are recognized to act as ligands for β2-integrins such as those produced during coagulation and complement pathway activation, which could mediate neutrophil adhesion and infiltration into the ischemic liver [3639]. Therefore, evidence supports this study's finding that ICAM-1 deficiency does not play a key role in neutrophil infiltration and hepatic injury, and that other compensatory mechanisms exist to fulfill the role of ICAM-1.

Inflammatory cytokines such as TNF-α and IL-6 have been shown to play key roles in the pathophysiology of hepatic I/R injury [2, 17, 40]. TNF-α is the proximal cytokine that is expressed following hepatic I/R, and correlates with hepatic reperfusion injury. IL-6 is a multifunctional cytokine that is both pro-mitogenic and anti-apoptotic for hepatocytes, and is considered a marker for tissue injury severity [41, 42]. The data from this study corroborates this as it was found that TNF-α and IL-6 levels paralleled ALT plasma levels (Figure 5A. and 5B). There was no significant difference in plasma TNF-α, and IL-6 levels between the wild-type and P/I null mice.

The CXC-chemokine production was also examined in this study. Plasma MIP-2 and KC levels in the sham groups were constant and minimal, and a significant increase was induced by hepatic I/R in both wild-type and P/I null mice (Figure 5C. and 5D). However, in contrast to the plasma TNF-α and IL-6, a significant difference was observed between the wild-type and P/I null mice CXC-chemokine levels after 6 h of reperfusion. This is a novel observation and the exact mechanism to explain the reduced chemokine production in P/I null mice in response to hepatic I/R is not known, though it may be postulated that the adhesion molecule deficiency may play a role. The genetic knockout mice have altered expression of other molecules which may have reflected the expression of the chemokines. In support of this study, a recent report showed significantly lower chemokine production (i.e. KC) in P/E-selectin deficient mice than their wild-type counterparts [43]. In addition, a recent study highlights the role of selectins and non-integrin collagen receptors in chemokine production and function through p38 mitogen-activated protein kinase and NF-κB activation [44]. Further studies are necessary to examine the role of these adhesion molecules in chemokine regulation and their pathophysiologic role in different organ systems.

Previous studies have suggested a direct association between CXC-chemokines, neutrophil recruitment and liver injury. Specifically, blockage of CXC-chemokines with antibodies was associated with neutrophil infiltration and liver injury in the rat and mouse models of warm hepatic I/R [2, 40]. This is in part consistent with the wild-type data presented in this study, in that the CXC-chemokine levels correlated with liver injury and neutrophil infiltration during the early-phase of hepatic I/R (i.e. 6 h of reperfusion). However, during the late-phase of hepatic I/R (i.e. 15 h of reperfusion), the CXC-chemokines were at baseline levels, while neutrophil infiltration was maximal. The neutrophil infiltration may have been mediated by other more potent chemoattractants (e.g. C5a, LTB4) and mediators (e.g. apoptotic cells). This hypothesis is supported by Dorman et al's study, in which a CXC-independent neutrophil infiltration into the liver was found in response to apoptotic cells in a mouse model of endotoximia [45]. They showed that wild type as well as the CXCR2 -/- mice had similar neutrophil infiltration and liver injury. There are other potential factors to explain why neutrophil trafficking was not associated with chemokine production. One possible explanation is that the generated CXC-chemokine in P/I null mice was at its optimal concentration to mediate neutrophil infiltration and liver injury. Further, other inflammatory mediators may have been involved in neutrophil infiltration (e.g. C5a, LTB4). Finally, the nature of hepatic sinusoidal endothelium, which is fenestrated, may have allowed direct adhesion of neutrophils to the hepatocytes, resulting in liver damage. Future studies are necessary to examine the potential role of these various factors in neutrophil infiltration in hepatic I/R injury.

The survival data presented in this study showed that although not statistically significant the P/I null mice exhibited a favorable trend toward increased survival than their wild-type counterparts. The data also suggested that the potential survival advantage of P/I null mice was not a result of decreased hepatic injury. Since local organ injury appeared to be similar between both groups, it is likely that the P/I null mice were less susceptible to the systemic manifestations of hepatic I/R injury, such as acute respiratory distress syndrome, and multiple organ dysfunction syndrome [46]. It has yet to be elucidated though, whether the decreased CXC-chemokines had a potential role in favoring the survival. A previously published study demonstrated that P-selectin inhibition improved the survival of mice subjected to warm intestinal I/R, in which T lymphocytes (with Th2 profile) played a central role [47]. This is further supported by a study that has implicated CD4+T-lymphocytes as key regulators in I/R-induced inflammatory response in the liver [48]. The profile of Th1 and Th2 cytokines in P/I null mice has not been studied and as such, future studies are warranted to examine the role of T lymphocytes, in their contribution to increased survival.

In summary, the results of this study suggest that P-selectin and ICAM-1 adhesion molecules do not play a critical role in mediating neutrophil infiltration and liver injury caused by hepatic I/R. However, these adhesion molecules may play a role in CXC-chemokine regulation, which may exhibit other functions than chemotactic activities. Inhibition of these adhesion molecules may enhance overall survival by playing a role in the systemic organ injury that often ensues following liver I/R.


ICAM-1 :

Intercellular adhesion molecule-1

I/R :


IL-6 :


LFA-1 :

lymphocyte function-associated antigen

mAbs :

monoclonal antibodies



P/I null mice :

P-selectin/ICAM-1-deficient mice


tumor necrosis factor

WT :



  1. Carden DL, Granger DN: Pathophysiology of ischaemia-reperfusion injury. JPathol. 2000, 190: 255-10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6.

    Article  CAS  Google Scholar 

  2. Colletti LM, Kunkel SL, Walz A, Burdick MD, Kunkel RG, Wilke CA, Strieter RM: The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat. Hepatology. 1996, 23: 506-10.1002/hep.510230315.

    Article  PubMed  CAS  Google Scholar 

  3. Jaeschke H, Farhood A: Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am J Physiol. 1991, 260: G355-

    PubMed  CAS  Google Scholar 

  4. Jaeschke H, Hasegawa T: Role of neutrophils in acute inflammatory liver injury. Liver Int. 2006, 26: 912-9. 10.1111/j.1478-3231.2006.01327.x.

    Article  PubMed  CAS  Google Scholar 

  5. Lobb RR: Integrin-Immunoglobulin superfamily interactions in endothelial-leukocyte adhesion. Adhesion – Its role in inflammatory disease. Edited by: Harlan JM, Liu DY. 1992, Freeman Press, 1-18.

    Google Scholar 

  6. Crockett-Torabi E, Sullenbarger B, Smith CW, Fantone JC: Neutrophil activation through L-selectin and Mac-1. J Immunol. 1995, 154: 2291-

    PubMed  CAS  Google Scholar 

  7. Chosay JG, Essani NA, Dunn CJ, Jaeschke H: Neutrophil margination and extravasation in sinusoids and venules of liver during endotoxin-induced injury. Am J Physiol. 1997, 272: G1195-

    PubMed  CAS  Google Scholar 

  8. Ganey PE, Bailie MB, VanCise S, Colligan ME, Madhukar BV, Robinson JP, Roth RA: Activated neutrophils from rat injured isolated hepatocytes. Lab Invest. 1994, 70: 53-

    PubMed  CAS  Google Scholar 

  9. Dulkanchainun TS, Goss JA, Imagawa DK, Shaw GD, Anselmo DM, Kaldas F, Wang T, Zhao D, Busuttil AA, Kato H, Murray NG, Kupiec-Weglinski JW, Busuttil RW: Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1. Ann SurgI. 1998, 227: 832-10.1097/00000658-199806000-00006.

    Article  CAS  Google Scholar 

  10. Farhood A, McGuire GM, Manning AM, Miyasaka M, Smith CW, Jaeschke H: Intercellular adhesion molecule 1 (ICAM-1) expression and its role in neutrophil-induced ischemia-reperfusion injury in rat liver. J Leukoc Biol. 1995, 57: 368-

    PubMed  CAS  Google Scholar 

  11. Singh I, Zibari GB, Zizzi H, Granger DN, Cruz L, Gonsales E, McDonald JC, Brown MF: Anti-P-selectin antibody protects against hepatic ichemia-reperfusion injury. Transplant Proc. 1998, 30: 2324-10.1016/S0041-1345(98)00640-X.

    Article  PubMed  CAS  Google Scholar 

  12. Bullard DC, Qin L, Lorenzo I, Quinlin WM, Doyle NA, Bosse R, Vestweber D, Doerschuk CM, Beaudet AL: P-selectin/ICAM-1 double mutant mice: acute emigration of neutrophils into the peritoneum is completely absent but is normal into pulmonary alveoli. J Clin Invest. 1995, 95: 1782-

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  13. Young CS, Palma JM, Mosher BD, Harkema J, Naylor DF, Dean RE, Crockett E: Hepatic ischemia/reperfusion injury in P-selectin and intercellular adhesion molecule-1 double-mutant mice. Am Surg. 2001, 67: 737-

    PubMed  CAS  Google Scholar 

  14. Essani NA, Fisher MA, Simmons CA, Hoover JL, Farhood A, Jaeschke H: Increased P-selectin gene expression in the liver vasculature and its role in the pathophysiology of neutrophil-induced hepatic injury in murine endotoxin shock. J Leukoc Biol. 1998, 63: 288-

    PubMed  CAS  Google Scholar 

  15. Wong J, Johnston B, Lee SS, Bullard DC, Smith CW, Beaudet AL, Kubes P: A minimal role for selectins in the recruitment of leukocytes into the inflamed liver microvasculature. J Clin Invest. 1997, 99: 2782-

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  16. Harlan JM, Winn RK: Leukocyte-endothelial interactions: Clinical trials of anti-adhesion therapy. Crit Care Med. 2002, 30: S214-10.1097/00003246-200205001-00007.

    Article  PubMed  CAS  Google Scholar 

  17. Mosher BD, RE Dean, J Harkema, D Remick, J Palma, Crockett E: Inhibition of chemokines production by kupffer cells decreased hepatic ischemia/reperfusion injury in mice. J Surgical Research. 2001, 99: 201-10.1006/jsre.2001.6217.

    Article  CAS  Google Scholar 

  18. Essani NA, Fisher MA, Farhood A, Manning AM, Smith CW, Jaeschke H: Cytokine-induced upregulation of hepatic intercellular adhesion molecule-1 messenger RNA expression and its role in the pathophysiology of murine endotoxin shock and acute liver failure. Hepatology. 1995, 21: 1632-

    PubMed  CAS  Google Scholar 

  19. Hill J, Lindsay T, Rusche J, Valeri CR, Shepro D, Hechtman HB: A Mac-1 antibody reduces hepatic and lung injury but not neutrophil sequestration after intestinal ischemia-reperfusion. Surgery. 1992, 112: 166-

    PubMed  CAS  Google Scholar 

  20. Jaeschke H, Farhood A, Fisher MA, Smith CW: Sequestration of neutrophils in the hepatic vasculature during endotoxemia is independent of beta 2 integrins and intercellular adhesion molecule-1. Shock. 1996, 6: 351-

    Article  PubMed  CAS  Google Scholar 

  21. Essani NA, McGuire GM, Manning AM, Jaeschke H: Differential induction of mRNA for ICAM-1 and selectins in hepatocytes, Kupffer cells and endothelial cells during endotoxemia. Biochem Biophys Res Commun. 1995, 211: 74-10.1006/bbrc.1995.1780.

    Article  PubMed  CAS  Google Scholar 

  22. Wisse E: An ultrastructural characterization of the endothelial cell in the rat liver sinusoid under normal and various experimental conditions, as a contribution to the distinction between endothelial and Kupffer cells. J Ultrastruct Res. 1972, 38: 528-10.1016/0022-5320(72)90089-5.

    Article  PubMed  CAS  Google Scholar 

  23. Steinhoff G, Behrend M, Schrader B, Duijvestijn AM, Wonigeit K: Expression patterns of leukocyte adhesion ligand molecules on human liver endothelia. Lack of ELAM-1 and CD62 inducibility on sinusoidal endothelia and distinct distribution of VCAM-1, ICAM-1, ICAM-2, and LFA-3. Am J Pathol. 1993, 142: 481-

    PubMed  CAS  PubMed Central  Google Scholar 

  24. Fox-Robichaud A, Kubes P: Molecular mechanisms of tumor necrosis factor alpha-stimulated leukocyte recruitment into the murine hepatic circulation. Hepatology. 2000, 31: 1123-7. 10.1053/he.2000.6961.

    Article  PubMed  CAS  Google Scholar 

  25. Yadav SS, Howell DN, Steeber DA, Harland RC, Tedder TF, Clavien PA: P-Selectin mediates reperfusion injury through neutrophil and platelet sequestration in the warm ischemic mouse liver. Hepatology. 1999, 29: 1494-502. 10.1002/hep.510290505.

    Article  PubMed  CAS  Google Scholar 

  26. McCuskey RS, Urbaschek R, Urbaschek B: The microcirculation during endotoxemia. Cardiovasc Res. 1996, 32: 752-10.1016/0008-6363(96)00113-7.

    Article  PubMed  CAS  Google Scholar 

  27. Worthen GS, Schwab B, Elson EL, Downey GP: Mechanics of stimulated neutrophils: cell stiffening induces retention in capillaries. Science. 1989, 245: 183-10.1126/science.2749255.

    Article  PubMed  CAS  Google Scholar 

  28. King PD, Sandberg ET, Selvakumar A, Fang P, Beauder AL, Dupont B: Novel isoforms of murine intercellular adhesion molecule-1 generated by alternative RNA splicing. J Immunology. 1995, 154: 6080-6093.

    CAS  Google Scholar 

  29. van Den Engel NK, Heidenthal E, Vinke A, Kolb H, Martin S: Circulating forms of intercellular adhesion molecule (ICAM)-1 in mice lacking membranous ICAM-1. Blood. 2000, 95: 1350-5.

    PubMed  CAS  Google Scholar 

  30. Huang MT, Larbi KY, Scheiermann C, Woodfin A, Gerwin N, Haskard DO, Nourshargh S: ICAM-2 mediates neutrophil transmigration in vivo: evidence for stimulus specificity and a role in PECAM-1-independent transmigration. Blood. 2006, 107: 4721-7. 10.1182/blood-2005-11-4683.

    Article  PubMed  CAS  Google Scholar 

  31. Molla M, Gironella M, Miquel R, Tovar V, Engel P, Biete A, Pique JM, Panes J: Relative roles of ICAM-1 and VCAM-1 in the pathogenesis of experimental radiation-induced intestinal inflammation. Int J Radiat Oncol Biol Phys. 2003, 57: 264-73. 10.1016/S0360-3016(03)00523-6.

    Article  PubMed  CAS  Google Scholar 

  32. Johnston B, Kubes P: The alpha4-integrin: an alternative pathway for neutrophil recruitment. Immunol Today. 1999, 20: 545-50. 10.1016/S0167-5699(99)01544-3.

    Article  PubMed  CAS  Google Scholar 

  33. Bowden RA, Ding ZM, Donnachie EM, Petersen TK, Michael LH, Ballantyne CM, Burns AR: Role of alpha4 integrin and VCAM-1 in CD18-independent neutrophil migration across mouse cardiac endothelium. Circ Res. 2002, 90: 562-9. 10.1161/01.RES.0000013835.53611.97.

    Article  PubMed  CAS  Google Scholar 

  34. Ibbotson GC, Doig C, Kaur J, Gill V, Ostrovsky L, Fairhead T, Kubes P: Functional alpha4-integrin: a newly identified pathway of neutrophil recruitment in critically ill septic patients. Nat Med. 2001, 7: 465-70. 10.1038/86539.

    Article  PubMed  CAS  Google Scholar 

  35. Taooka Y, Chen J, Yednock T, Sheppard D: The integrin alpha9beta1 mediates adhesion to activated endothelial cells and transendothelial neutrophil migration through interaction with vascular cell adhesion molecule-1. J Cell Biol. 1999, 145: 413-20. 10.1083/jcb.145.2.413.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  36. Suzuki K, Watanabe T, Sakurai S, Ohtake K, Kinoshita T, Araki A, Fujita T, Takei H, Takeda Y, Sato Y, Yamashita T, Araki Yoshihiko, Sendo F: A novel glycosylphosphatidyl inositol-anchored protein on human leukocytes: A possible role for regulation of neutrophil adherence and migration. J Immunol. 1999, 162: 4277-4284.

    PubMed  CAS  Google Scholar 

  37. Gross TJ, Leavell KJ, Peterson MW: CD11b/CD18 mediates the neutrophil chemotactic activity of fibrin degradation product D domain. Thromb Haemost. 1997, 77: 894-900.

    PubMed  CAS  Google Scholar 

  38. Siegbahn A: Cellular consequences upon factor VIIa binding to tissue factor. Haemostasis. 2000, 2: 41-7. 10.1159/000054162.

    Google Scholar 

  39. Bombeli T, Schwartz BR, Harlan JM: Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha. J Exp Med. 1998, 187: 329-10.1084/jem.187.3.329.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  40. Lentsch AB, Yoshidome H, Cheadle WG, Miller FN, Edwards MJ: Chemokine involvement in hepatic ischemia/reperfusion injury in mice: Roles for macrophage inflammatory protein-2 and KC. Hepatology. 1998, 27: 563-568. 10.1002/hep.510270226.

    Article  Google Scholar 

  41. Teoh N, Field J, Farrell G: IL-6 is one likely mediator of the hepatoprotective and pro-proliferative effects of ischaemic preconditioning. J Hepatol. 2006, 45: 20-7. 10.1016/j.jhep.2006.01.039.

    Article  PubMed  CAS  Google Scholar 

  42. Jin X, Zimmers TA, Perez EA, Pierce RH, Zhang Z, Koniaris LG: Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair. Hepatology. 2006, 43: 474-84. 10.1002/hep.21087.

    Article  PubMed  CAS  Google Scholar 

  43. Li Z, Burns AR, Smith CW: Two waves of neutrophil emigration in response to corneal epithelial abrasion: distinct adhesion molecule requirements. Invest Ophthalmol Vis Sci. 2006, 47: 1947-55. 10.1167/iovs.05-1193.

    Article  PubMed  Google Scholar 

  44. Matsuyama W, Wang L, Farrar WL, Faure M, Yoshimura T: Activation of discoidin domain receptor 1 isoform b with collagen up-regulates chemokine production in human macrophages: role of p38 mitogen-activated protein kinase and NF-kappa B. J Immunol. 2004, 172: 2332-40.

    Article  PubMed  CAS  Google Scholar 

  45. Dorman RB, Gujral JS, Bajt ML, Farhood A, Jaeschke H: Generation and functional significance of CXC chemokines for neutrophil-induced liver injury during endotoxemia. Am J Physiol Gastrointest Liver Physiol. 2005, 288: G880-6. 10.1152/ajpgi.00317.2004.

    Article  PubMed  CAS  Google Scholar 

  46. Liu DL, Jeppsson B, Hakansson CH, Odselius R: Multiple-system organ damage resulting from prolonged hepatic inflow interruption. Arch Surg. 1996, 131: 442-

    Article  PubMed  CAS  Google Scholar 

  47. Farmer DG, Shen XD, Amersi F, Anselmo D, Ma JP, Ke B, Gao F, Dry S, Fernandez S, Shaw GD, McDiarmid SV, Busuttil RW, Kupiec-Weglinski J: CD62 blockade with P-Selectin glycoprotein ligand-immunoglobulin fusion protein reduces ischemia-reperfusion injury after rat intestinal transplantation. Transplantation. 2005, 79: 44-51. 10.1097/01.TP.0000146965.64706.E8.

    Article  PubMed  CAS  Google Scholar 

  48. Zwacka RM, Zhang Y, Halldorson J, Schlossberg H, Dudus L, Engelhardt JF: CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. J Clin Invest. 1997, 100: 279-89.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

Download references


The authors would like to thank the Department of Surgery – College of Human Medicine, and the McLaren Foundation at Michigan State University for providing funding. The authors would also like to thank Crystal Remelius, and Karen Hess for their technical assistance in cytokine analysis, and immuno-staining of the tissue samples in this research project.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Elahé T Crockett.

Additional information

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

This study represents parts of the Research Thesis project performed by KM under the direction of EC. KM carried out the surgical operation, collection of samples, analysis and interpretation of the MPO and ALT data, as well as drafting the manuscript. SD participated in the analysis of the cytokine data and the preparation of the manuscript. EC was responsible for conceiving, supervising the design and performance of the project, as well as preparation of the manuscript. All authors read and approved the manuscript.

Authors’ original submitted files for images

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and permissions

About this article

Cite this article

Monson, K.M., Dowlatshahi, S. & Crockett, E.T. CXC-chemokine regulation and neutrophil trafficking in hepatic ischemia-reperfusion injury in P-selectin/ICAM-1 deficient mice. J Inflamm 4, 11 (2007).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: